How M.S. was paid
$3.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Sanjay S. Shukla, M.D., M.S.President and CEO | $638,977 | $2,595,200 | $210,862 | $11,214 | $3,456,253 |
| Jill M. BroadfootChief Financial Officer | $471,790 | $713,680 | $113,229 | $11,214 | $1,309,913 |
| Nancy E. DenyesGeneral Counsel | $451,570 | $713,680 | $108,377 | $11,214 | $1,284,841 |
What changed and why
- $3.5MSanjay S. Shukla received total compensation of $3,456,253 in 2025.
- 10.0%Named executive officers received a 10.0% base salary market adjustment for 2025.
- 60%Performance-based bonuses were paid out at a 60% achievement level for 2025.
- Annual stock option grants were increased compared to prior years to maintain ownership percentages.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.